Teva Wins Challenge To Novartis' Blood Transfusion Patent

By Silvia Martelli (November 11, 2022, 4:40 PM GMT) -- Generic drug manufacturer Teva has succeeded in its bid to invalidate two patents owned by Novartis AG, as a London court found that the pharmaceutical giant's intellectual property for a blood transfusion medicine lacked novelty....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!